Obstetrics & Gynecology Doctors in Olive Branch, MS Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Laxmisilpa Gadiparthi Hansen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5480 Goodman Rd, Suite 2, Olive Branch, MS 38654 Phone: 662-893-9885    Fax: 662-893-9888

Ja'larna J Grant, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4240 Bethel Rd Ste 101, Olive Branch, MS 38654 Phone: 662-932-9544    Fax: 662-932-9554

Charles G Ryan Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6819 Crumpler Blvd Ste 101, Olive Branch, MS 38654 Phone: 662-890-5559    Fax: 662-893-8323

Dr. Sarah Kathleen Ziebarth, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4240 Bethel Rd Ste 101, Olive Branch, MS 38654 Phone: 662-932-9544    Fax: 662-932-9554

Dabney J Hamner Jr., M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4240 Bethel Rd Ste 101, Olive Branch, MS 38654 Phone: 662-932-9544    Fax: 662-932-9554

News Archive

Research suggests new pathway for preventing optic nerve damage in KPro recipients

Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.

Researchers create new method to analyze big data for better predictions

Researchers at Princeton, Columbia and Harvard have created a new method to analyze big data that better predicts outcomes in health care, politics and other fields.

Employers packaging next year's benefits plans confront overhaul

Some employers are finding that the health coverage they buy for their employees is changing, and that the health law may be responsible, KUOW, a Washington state NPR-affiliate, reports.

Research studies may lead to future development of cell transplant therapy for ALS

The University of California, San Diego, The Salk Institute for Biological Studies and Life Technologies Corporation today announced the initiation of studies which may lead to the future development of cell transplant therapy for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. Currently, there is only one FDA-approved pharmaceutical addressing this lethal disease, which affects approximately 30,000 people in the United States.

Read more Medical News

› Verified 1 days ago